They further investigated this hypothesis using whole exome sequencing by identifying 221 “true” FH patients (i.e., with pathogenic mutations on the LDLR, APOB, or PCSK9 genes) out of 37,486 individuals in the UK Biobank, without prior knowledge of their clinical history. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.